|
1
|
Solez K, Colvin RB, Racusen LC, Sis B,
Halloran PF, Birk PE, Campbell PM, Cascalho M, Collins AB, Demetris
AJ, et al: Banff '05 Meeting Report: Differential diagnosis of
chronic allograft injury and elimination of chronic allograft
nephropathy (‘CAN’). Am J Transplant. 7:518–526. 2007.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Solez K, Colvin RB, Racusen LC, Haas M,
Sis B, Mengel M, Halloran PF, Baldwin W, Banfi G, Collins AB, et
al: Banff 07 classification of renal allograft pathology: Updates
and future directions. Am J Transplant. 8:753–760. 2008.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Munn DH, Zhou M, Attwood JT, Bondarev I,
Conway SJ, Marshall B, Brown C and Mellor AL: Prevention of
allogeneic fetal rejection by tryptophan catabolism. Science.
281:1191–1193. 1998.PubMed/NCBI View Article : Google Scholar
|
|
4
|
King NJC and Thomas SR: Molecules in
focus: Indoleamine 2,3-dioxygenase. Int J Biochem Cell Biol.
39:2167–2172. 2007.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Curti A, Trabanelli S, Salvestrini V,
Baccarani M and Lemoli RM: The role of indoleamine 2,3-dioxygenase
in the induction of immune tolerance: Focus on hematology. Blood.
113:2394–2401. 2009.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Munn DH, Sharma MD, Baban B, Harding HP,
Zhang Y, Ron D and Mellor AL: GCN2 kinase in T cells mediates
proliferative arrest and anergy induction in response to
indoleamine 2,3-dioxygenase. Immunity. 22:633–642. 2005.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Mezrich JD, Fechner JH, Zhang X, Johnson
BP, Burlingham WJ and Bradfield CA: An interaction between
kynurenine and the aryl hydrocarbon receptor can generate
regulatory T cells. J Immunol. 185:3190–3198. 2010.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Eleftheriadis T, Pissas G, Yiannaki E,
Markala D, Arampatzis S, Antoniadi G, Liakopoulos V and Stefanidis
I: Inhibition of indoleamine 2,3-dioxygenase in mixed lymphocyte
reaction affects glucose influx and enzymes involved in aerobic
glycolysis and glutaminolysis in alloreactive T-cells. Hum Immunol.
74:1501–1509. 2013.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Eleftheriadis T, Pissas G, Antoniadi G,
Spanoulis A, Liakopoulos V and Stefanidis I: Indoleamine
2,3-dioxygenase increases p53 levels in alloreactive human T cells,
and both indoleamine 2,3-dioxygenase and p53 suppress glucose
uptake, glycolysis and proliferation. Int Immunol. 26:673–684.
2014.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Eleftheriadis T, Pissas G, Antoniadi G,
Liakopoulos V and Stefanidis I: Indoleamine 2,3-dioxygenase
depletes tryptophan, activates general control non-derepressible 2
kinase and down-regulates key enzymes involved in fatty acid
synthesis in primary human CD4+ T cells. Immunology. 146:292–300.
2015.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Eleftheriadis T, Pissas G, Antoniadi G,
Tsogka K, Sounidaki M, Liakopoulos V and Stefanidis I: Indoleamine
2,3 dioxygenase downregulates T cell receptor complex ζ chain and c
Myc, and reduces proliferation, lactate dehydrogenase levels and
mitochondrial glutaminase in human T cells. Mol Med Rep.
13:925–932. 2016.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Eleftheriadis T, Pissas G, Sounidaki M,
Tsogka K, Antoniadis N, Antoniadi G, Liakopoulos V and Stefanidis
I: Indoleamine 2,3-dioxygenase, by degrading L-tryptophan, enhances
carnitine palmitoyltransferase I activity and fatty acid oxidation,
and exerts fatty acid-dependent effects in human alloreactive
CD4+ T-cells. Int J Mol Med. 38:1605–1613.
2016.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Vavrincova-Yaghi D, Deelman LE, Goor H,
Seelen M, Kema IP, Smit-van Oosten A, Zeeuw D, Henning RH and
Sandovici M: Gene therapy with adenovirus-delivered indoleamine
2,3-dioxygenase improves renal function and morphology following
allogeneic kidney transplantation in rat. J Gene Med. 13:373–381.
2011.PubMed/NCBI View
Article : Google Scholar
|
|
14
|
Sun X, Gong ZJ, Wang ZW, Li T, Zhang JY,
Sun HC, Liu S, Huang L, Huang C and Peng ZH: IDO-competent-DCs
induced by IFN-γ attenuate acute rejection in rat liver
transplantation. J Clin Immunol. 32:837–847. 2012.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Iken K, Liu K, Liu H, Bizargity P, Wang L,
Hancock WW and Visner GA: Indoleamine 2,3-dioxygenase and
metabolites protect murine lung allografts and impair the calcium
mobilization of T cells. Am J Respir Cell Mol Biol. 47:405–416.
2012.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Hosseini-Tabatabaei A, Jalili RB,
Khosravi-Maharlooei M, Hartwell R, Kilani RT, Zhang Y and Ghahary
A: Immunoprotection and Functional Improvement of Allogeneic Islets
in Diabetic Mice, Using a Stable Indoleamine 2,3-Dioxygenase
Producing Scaffold. Transplantation. 99:1341–1348. 2015.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Xie FT, Cao JS, Zhao J, Yu Y, Qi F and Dai
XC: IDO expressing dendritic cells suppress allograft rejection of
small bowel transplantation in mice by expansion of Foxp3+
regulatory T cells. Transpl Immunol. 33:69–77. 2015.PubMed/NCBI View Article : Google Scholar
|
|
18
|
He Y, Zhou S, Liu H, Shen B, Zhao H, Peng
K and Wu X: Indoleamine 2,3-Dioxgenase Transfected Mesenchymal Stem
Cells Induce Kidney Allograft Tolerance by Increasing the
Production and Function of Regulatory T cells. Transplantation.
99:1829–1838. 2015.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Ebrahimi A, Kardar GA, Teimoori-Toolabi L,
Ghanbari H and Sadroddiny E and Sadroddiny E: Inducible expression
of indoleamine 2,3-dioxygenase attenuates acute rejection of
tissue-engineered lung allografts in rats. Gene. 576:412–420.
2016.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Li C, Liu T, Zhao N, Zhu L, Wang P and Dai
X: Dendritic cells transfected with indoleamine 2,3-dioxygenase
gene suppressed acute rejection of cardiac allograft. Int
Immunopharmacol. 36:31–38. 2016.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Na N, Luo Y, Zhao D, Yang S, Hong L, Li H,
Miao B and Qiu J: Prolongation of kidney allograft survival
regulated by indoleamine 2, 3-dioxygenase in immature dendritic
cells generated from recipient type bone marrow progenitors. Mol
Immunol. 79:22–31. 2016.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Khosravi-Maharlooei M, Pakyari M, Jalili
RB, Kilani RT and Ghahary A: Intraperitoneal injection of
IDO-expressing dermal fibroblasts improves the allograft survival.
Clin Immunol. 174:1–9. 2017.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Jia L, Schweikart K, Tomaszewski J, Page
JG, Noker PE, Buhrow SA, Reid JM, Ames MM and Munn DH: Toxicology
and pharmacokinetics of 1-methyl-d-tryptophan: Absence of toxicity
due to saturating absorption. Food Chem Toxicol. 46:203–211.
2008.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Alexander AM, Crawford M, Bertera S,
Rudert WA, Takikawa O, Robbins PD and Trucco M: Indoleamine
2,3-dioxygenase expression in transplanted NOD Islets prolongs
graft survival after adoptive transfer of diabetogenic splenocytes.
Diabetes. 51:356–365. 2002.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Sakurai K, Zou J-P, Tschetter JR, Ward JM
and Shearer GM: Effect of indoleamine 2,3-dioxygenase on induction
of experimental autoimmune encephalomyelitis. J Neuroimmunol.
129:186–196. 2002.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Uyttenhove C, Pilotte L, Théate I,
Stroobant V, Colau D, Parmentier N, Boon T and Van den Eynde BJ:
Evidence for a tumoral immune resistance mechanism based on
tryptophan degradation by indoleamine 2,3-dioxygenase. Nat Med.
9:1269–1274. 2003.PubMed/NCBI View
Article : Google Scholar
|
|
27
|
Lowe G and Tansley G: An investigation of
the mechanism of activation of tryptophan by tryptophanyl-tRNA
synthetase from beef pancreas. Eur J Biochem. 138:597–602.
1984.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Kim SH, Henry EC, Kim DK, Kim YH, Shin KJ,
Han MS, Lee TG, Kang JK, Gasiewicz TA, Ryu SH, et al: Novel
compound 2-methyl-2H-pyrazole-3-carboxylic acid
(2-methyl-4-o-tolylazo-phenyl)-amide (CH-223191) prevents
2,3,7,8-TCDD-induced toxicity by antagonizing the aryl hydrocarbon
receptor. Mol Pharmacol. 69:1871–1878. 2006.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Eleftheriadis T, Pissas G, Antoniadi G,
Liakopoulos V, Tsogka K, Sounidaki M and Stefanidis I: Differential
effects of the two amino acid sensing systems, the GCN2 kinase and
the mTOR complex 1, on primary human alloreactive CD4+
T-cells. Int J Mol Med. 37:1412–1420. 2016.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Eleftheriadis T, Pissas G, Antoniadi G,
Liakopoulos V and Stefanidis I: Kynurenine, by activating aryl
hydrocarbon receptor, decreases erythropoietin and increases
hepcidin production in HepG2 cells: A new mechanism for anemia of
inflammation. Exp Hematol. 44:60–7, e1. 2016.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Berridge MV, Herst PM and Tan AS:
Tetrazolium dyes as tools in cell biology: New insights into their
cellular reduction. Biotechnol Annu Rev. 11:127–152.
2005.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Eleftheriadis T, Pissas G, Karioti A,
Antoniadi G, Liakopoulos V, Dafopoulou K, Pournaras S, Koukoulis G
and Stefanidis I: The indoleamine 2,3-dioxygenase inhibitor
1-methyl-tryptophan suppresses mitochondrial function, induces
aerobic glycolysis and decreases interleukin-10 production in human
lymphocytes. Immunol Invest. 41:507–520. 2012.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Meo T: The MLR test in the mouse. In:
Immunological methods. Lefkovits I and Pernis B (eds). Academic
Press, New York, NY. pp227–239. 1979.
|
|
34
|
Rümke HC, Terpstra FG, Huis B, Out TA and
Zeijlemaker WP: Immunoglobulin production in human mixed lymphocyte
cultures: Implications for co-cultures of cells from patients and
healthy donors. J Immunol. 128:696–701. 1982.PubMed/NCBI
|
|
35
|
Konishi E, Kitai Y and Kondo T:
Utilization of complement-dependent cytotoxicity to measure low
levels of antibodies: Application to nonstructural protein 1 in a
model of Japanese encephalitis virus. Clin Vaccine Immunol.
15:88–94. 2008.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Sato T, Deiwick A, Raddatz G, Koyama K and
Schlitt HJ: Interactions of allogeneic human mononuclear cells in
the two-way mixed leucocyte culture (MLC): Influence of cell
numbers, subpopulations and cyclosporin. Clin Exp Immunol.
115:301–308. 1999.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Cai LJ, Yu DW, Gao Y, Yang C, Zhou HM and
Chen ZK: Activation of aryl hydrocarbon receptor prolongs survival
of fully mismatched cardiac allografts. J Huazhong Univ Sci
Technolog Med Sci. 33:199–204. 2013.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Lee JA, Hwang JA, Sung HN, Jeon CH, Gill
BC, Youn HJ and Park JH: 2,3,7,8-Tetrachlorodibenzo-p-dioxin
modulates functional differentiation of mouse bone marrow-derived
dendritic cells Downregulation of RelB by
2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol Lett. 173:31–40.
2007.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Julliard W, Fechner JH and Mezrich JD: The
aryl hydrocarbon receptor meets immunology: Friend or foe? A little
of both. Front Immunol. 5(458)2014.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Panchanathan R, Liu H and Choubey D:
Activation of p53 in Human and Murine Cells by DNA-Damaging Agents
Differentially Regulates Aryl Hydrocarbon Receptor Levels. Int J
Toxicol. 34:242–249. 2015.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Shinde R, Shimoda M, Chaudhary K, Liu H,
Mohamed E, Bradley J, Kandala S, Li X, Liu K and McGaha TL: B
cell-Intrinsic IDO1 Regulates Humoral Immunity to T
cell-Independent Antigens. J Immunol. 195:2374–2382.
2015.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Criado G, Simelyte E, Inglis JJ, Essex D
and Williams RO: Indoleamine 2,3 dioxygenase-mediated tryptophan
catabolism regulates accumulation of Th1/Th17 cells in the joint in
collagen-induced arthritis. Arthritis Rheum. 60:1342–1351.
2009.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Scott GN, DuHadaway J, Pigott E, Ridge N,
Prendergast GC, Muller AJ and Mandik-Nayak L: The immunoregulatory
enzyme IDO paradoxically drives B cell-mediated autoimmunity. J
Immunol. 182:7509–7517. 2009.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Xu H, Oriss TB, Fei M, Henry AC, Melgert
BN, Chen L, Mellor AL, Munn DH, Irvin CG, Ray P, et al: Indoleamine
2,3-dioxygenase in lung dendritic cells promotes Th2 responses and
allergic inflammation. Proc Natl Acad Sci USA. 105:6690–6695.
2008.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Merlo LMF, Pigott E, DuHadaway JB, Grabler
S, Metz R, Prendergast GC and Mandik-Nayak L: IDO2 is a critical
mediator of autoantibody production and inflammatory pathogenesis
in a mouse model of autoimmune arthritis. J Immunol. 192:2082–2090.
2014.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Merlo LMF, DuHadaway JB, Grabler S,
Prendergast GC, Muller AJ and Mandik-Nayak L: IDO2 Modulates T
cell-Dependent Autoimmune Responses through a B Cell-Intrinsic
Mechanism. J Immunol. 196:4487–4497. 2016.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Yoshida T, Katsuya K, Oka T, Koizumi S,
Wakita D, Kitamura H and Nishimura T: Effects of AhR ligands on the
production of immunoglobulins in purified mouse B cells. Biomed
Res. 33:67–74. 2012.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Wourms MJ and Sulentic CEW: The aryl
hydrocarbon receptor regulates an essential transcriptional element
in the immunoglobulin heavy chain gene. Cell Immunol. 295:60–66.
2015.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Eleftheriadis T, Liakopoulos V, Antoniadi
G, Stefanidis I and Galaktidou G: Indoleamine 2,3-dioxygenase is
increased in hemodialysis patients and affects immune response to
hepatitis B vaccination. Vaccine. 29:2242–2247. 2011.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Eleftheriadis T, Sparopoulou T, Antoniadi
G, Liakopoulos V, Stefanidis I and Galaktidou G: Suppression of
humoral immune response to hepatitis B surface antigen vaccine in
BALB/c mice by 1-methyl-tryptophan co-administration. Daru.
19:236–239. 2011.PubMed/NCBI
|
|
51
|
Patel AA, Zhang Y, Fullerton JN, Boelen L,
Rongvaux A, Maini AA, Bigley V, Flavell RA, Gilroy DW, Asquith B,
et al: The fate and lifespan of human monocyte subsets in steady
state and systemic inflammation. J Exp Med. 214:1913–1923.
2017.PubMed/NCBI View Article : Google Scholar
|
